Hedge Funds Are Hunting Deals in Risks Too Big for Insurers April 7, 2025 By Natasha White As Los Angeles residents digested the apocalyptic scene left by wildfires earlier this year, the stage was simultaneously being set... Read More
Editor's Picks Tariffs Will Lead to 2M Fewer Auto Sales in US This Year, Firm Forecasts April 7, 2025 By Kalea Hall and Nora Eckert U.S. and Canada auto sales could decline by 1.8 million vehicles this year and be stagnant over the next decade... Read More
Viatris to Pay $335 Million to Resolve Opioid-Related Claims April 7, 2025 By Christy Santhosh Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement... Read More
Chevron to Pay $740 Million to Restore Louisiana’s Coast April 7, 2025 By Vallari Srivastava Chevron was ordered to pay $740 million to restore damages the oil and gas major caused to southeast Louisiana’s coastal... Read More
Half of Homeowners Fear Losing Insurance as Costs Rise, Survey Shows April 7, 2025 Half of homeowners worry their homes will be uninsurable in the future, a new survey shows. The results of a... Read More
HONK Names Teal EVP of Sales and Partnerships April 7, 2025 HONK has named Buck Teal executive vice president of sales and partnerships. Teal will lead efforts to grow revenue and... Read More
Editor's Picks Report Highlights Louisiana’s Tort System as Barrier to Social Mobility April 7, 2025 By Ezra Amacher A report published this week by a Washington, D.C.-based think tank ranks Louisiana as the worst state for social mobility,... Read More
Fed’s Powell Says Tariff Impact Likely to Be Larger Than Expected April 4, 2025 By Craig Torres and Amara Omeokwe Federal Reserve Chair Jerome Powell said the economic impact of new tariffs is likely to be significantly larger than expected,... Read More
TikTok’s New Owner Stands to Inherit 1,500 Safety, Privacy Suits April 4, 2025 By Peter Blumberg TikTok faces a mountain of litigation over child safety and privacy, a big risk for potential bidders vying to save... Read More
GSK Resolves Patent Lawsuit Against Pfizer Over RSV Vaccines April 4, 2025 By Blake Brittain British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer’s respiratory syncytial virus (RSV)... Read More